Induction of small cell lung cancer by somatic inactivation of both Trp53 and Rb1 in a conditional mouse model

Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses

Bhattacharjee, A., Richards, W. G., Staunton, J. E., Li, C., Monti, S., Vasa, P. P., Ladd, C., Beheshti, J., Bueno, R., Gillette, M. A., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191502998 · Cited by 2,558

Neuroblastoma: biological insights into a clinical enigma

Brodeur, G. M. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1014 · Cited by 2,161

Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-rasPreprint

Jackson, E. L., Willis, N. A., Mercer, K. L., Bronson, R. T., Crowley, D. G., Montoya, R., Jacks, T., & Tuveson, D. A. (2001) · Genes & Development · doi:10.1101/gad.943001 · Cited by 1,927

Effects of an Rb mutation in the mouse

Jacks, T., Fazeli, A., Schmitt, E. M., Bronson, R. T., Goodell, M. A., & Weinberg, R. A. (1992) · Nature · doi:10.1038/359295a0 · Cited by 1,755

The RB and p53 pathways in cancer

Sherr, C. J., & McCormick, F. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00102-2 · Cited by 1,690

Simplified mammalian DNA isolation procedure

Laird, P. W., Zijderveld, A., Linders, K., Rudnicki, M. A., Jaenisch, R., & Berns, A. J. M. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.15.4293 · Cited by 1,497

Diversity of gene expression in adenocarcinoma of the lung

Garber, M. E., Troyanskaya, O. G., Schlüns, K., Petersen, S., Thäsler, Z., Pacyna-Gengelbach, M., van de Rijn, M., Rosen, G., Perou, C. M., Whyte, R. I., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.241500798 · Cited by 1,301

Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer

Watkins, D. N., Berman, D. M., Burkholder, S. G., Wang, B., Beachy, P. A., & Baylin, S. B. (2003) · Nature · doi:10.1038/nature01493 · Cited by 1,082

Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer

Jonkers, J., Meuwissen, R. L. J., van der Gulden, H. M. L., Peterse, H. L., van der Valk, M., & Berns, A. J. M. (2001) · Nature Genetics · doi:10.1038/ng747 · Cited by 1,044

Induction of medulloblastomas in p53 -null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum

Marino, S., Vooijs, M., van der Gulden, H., Jonkers, J., & Berns, A. (2000) · Genes & Development · doi:10.1101/gad.14.8.994 · Cited by 920

Tumor agonist peptides break tolerance and elicit effective CTL responses in an inducible mouse model of hepatocellular carcinoma

Stahl, S. H., Sacher, T., Bechtold, A., Protzer, U., Ganß, R., Hämmerling, G. J., Arnold, B., & Garbi, N. (2009) · Immunology Letters · doi:10.1016/j.imlet.2009.01.011 · Cited by 27

Establishment and Characterization of a New Cell Line, A99, From a Primary Small Cell Carcinoma of the Pancreas

Yachida, S., Zhong, Y., Pătrașcu, R., Davis, M. B., Morsberger, L. A., Griffin, C. A., Hruban, R. H., Laheru, D. A., & Iacobuzio–Donahue, C. A. (2011) · Pancreas · doi:10.1097/mpa.0b013e3182207a58 · Cited by 26

Ras Regulates Rb via NORE1A

Barnoud, T., Donninger, H., & Clark, G. J. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.697557 · Cited by 26

SEMMs: Somatically Engineered Mouse Models. A New Tool for In Vivo Disease Modeling for Basic and Translational Research

Lima, A., & Maddalo, D. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.667189 · Cited by 24

Preclinical Models for the Study of Lung Cancer Pathogenesis and Therapy DevelopmentPreprint

Estape, A. A., Foggetti, G., Starrett, J. H., Nguyen, D. X., & Politi, K. A. (2021) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a037820 · Cited by 23

Clinicopathologic and molecular characteristics of EGFR-mutant lung adenocarcinomas that transform to small cell lung cancer after TKI therapy

Yu, L., Bazhenova, L. A., Gold, K. A., Tran, L., Hilburn, V., Vu, P., & Patel, S. P. (2022) · Translational Lung Cancer Research · doi:10.21037/tlcr-21-665 · Cited by 25

Retinoblastoma Expression and Targeting by CDK4/6 Inhibitors in Small Cell Lung Cancer

Wildey, G. M., Shay, A. M., McColl, K. S., Yoon, S., Shatat, M. A., Perwez, A., Spainhower, K. B., Kresak, A. M., Lipka, M., Yang, M., et al. (2022) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-22-0365 · Cited by 27

Significance of RB Loss in Unlocking Phenotypic Plasticity in Advanced Cancers

Venkadakrishnan, V. B., Yamada, Y., Weng, K., Idahor, O., & Beltran, H. (2023) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-23-0045 · Cited by 28

Treating Transcriptional Addiction in Small Cell Lung Cancer

Augert, A., & MacPherson, D. P. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.11.012 · Cited by 25

Identification of recurrent focal copy number variations and their putative targeted driver genes in ovarian cancer

Zhang, L., Yuan, Y., Lu, K. H., & Zhang, L. (2016) · BMC Bioinformatics · doi:10.1186/s12859-016-1085-7 · Cited by 25

Kdm1a promotes SCLC progression by transcriptionally silencing the tumor suppressor Rest

Jin, Y., Ma, D., Gramyk, T., Guo, C., Fang, R., Ji, H., & Shi, Y. G. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.05.118 · Cited by 25

The clinicopathologic of pulmonary adenocarcinoma transformation to small cell lung cancer

Yang, H., Liu, L., Zhou, C., Xiong, Y., Hu, Y., Yang, N., & Qu, J. (2019) · Medicine · doi:10.1097/md.0000000000014893 · Cited by 25

Relationship between Lung Carcinogenesis and Chronic Inflammation in Rodents

Nakano‐Narusawa, Y., Yokohira, M., Yamakawa, K., Ye, J., Tanimoto, M., Wu, L., Mukai, Y., Imaida, K., & Matsuda, Y. (2021) · Cancers · doi:10.3390/cancers13122910 · Cited by 26

PTEN Loss Expands the Histopathologic Diversity and Lineage Plasticity of Lung Cancers Initiated by Rb1/Trp53 Deletion

Zhang, L., Zhu, X., Liu, C., Zhang, B., Zheng, J., Singh, P. K., Bshara, W., Wang, J., Gomez, E. C., Zhang, X., et al. (2022) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2022.11.019 · Cited by 24

SV40 TAg mouse models of cancer

Colvin, E. K., Weir, C., Ikin, R. J., & Hudson, A. L. (2014) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2014.02.004 · Cited by 26

An orthotopic mouse model of small cell lung cancer reflects the clinical course in patients

Taromi, S., Kayser, G., von Elverfeldt, D., Reichardt, W., Braun, F., Weber, W., Zeiser, R., & Burger, M. (2016) · Clinical & Experimental Metastasis · doi:10.1007/s10585-016-9808-8 · Cited by 24

Prognostic impact of tumor mutation burden and the mutation in KIAA1211 in small cell lung cancer

Zhou, M., Fan, J., Li, Z., Li, P., Sun, Y., Yang, Y., Zhou, X., Wang, J., Wang, Y., Qi, H., et al. (2019) · Respiratory Research · doi:10.1186/s12931-019-1205-9 · Cited by 24

Preclinical Models of Neuroendocrine Neoplasia

Sedlack, A. J. H., Saleh-Anaraki, K., Kumar, S., Ear, P. H., Lines, K. E., Roper, N., Pacák, K., Bergsland, E. K., Quelle, D. E., Howe, J. R., et al. (2022) · Cancers · doi:10.3390/cancers14225646 · Cited by 25

Therapeutic targeting RORγ with natural product N-hydroxyapiosporamide for small cell lung cancer by reprogramming neuroendocrine fate

Chen, J., Hu, Y., Zhang, J., Wang, Q., Wu, X.-Z., Huang, W., Wang, Q., Cai, G., Wang, H., Ou, T., et al. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106160 · Cited by 23

Immune Checkpoint Blockade Outcome in Small-Cell Lung Cancer and Its Relationship With Retinoblastoma Mutation Status and Function

Dowlati, A., Abbas, A., Chan, T. A.-T., Henick, B. S., Wang, X., Doshi, P. D., Fu, P., Patel, J. D., Kuo, F., Chang, H., et al. (2022) · JCO Precision Oncology · doi:10.1200/po.22.00257 · Cited by 23

EHMT2-mediated transcriptional reprogramming drives neuroendocrine transformation in non–small cell lung cancer

Yang, C., Ma, S., Zhang, J., Han, Y., Wan, L., Zhou, W., Dong, X., Yang, W., Chen, Y., Gao, L., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2317790121 · Cited by 23

Undifferentiated State Induced by Rb-p53 Double Inactivation in Mouse Thyroid Neuroendocrine Cells and Embryonic Fibroblasts

Kitajima, S., Kohno, S., Kondoh, A., Sasaki, N., Nishimoto, Y., Li, F., Mohammed, M. S. A., Muranaka, H., Nagatani, N., Suzuki, M., et al. (2015) · Stem Cells · doi:10.1002/stem.1971 · Cited by 24

In Cultured Astrocytes, p53 and MDM2 Do Not Alter Hypoxia-inducible Factor-1α Function Regardless of the Presence of DNA Damage

Rempe, D. A., Lelli, K. M., Vangeison, G., Johnson, R. S., & Federoff, H. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702203200 · Cited by 23

A SWI/SNF-dependent transcriptional regulation mediated by POU2AF2/C11orf53 at enhancer

Szczepanski, A. P., Tsuboyama, N., Lyu, H., Wang, P., Beytullahoglu, O., Zhang, T., Singer, B. D., Yue, F., Zhao, Z., & Wang, L. (2024) · Nature Communications · doi:10.1038/s41467-024-46492-5 · Cited by 22

Analysis of unexpected small cell lung cancer following surgery as the primary treatment

Yang, H., Xu, J., Yao, F., Liang, S., & Zhao, H. (2018) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-018-2766-6 · Cited by 22

LZTR1 Mutation Mediates Oncogenesis through Stabilization of EGFR and AXL

Ko, A., Hasanain, M., Oh, Y. T., D’Angelo, F., Sommer, D., Frangaj, B., Tran, S., Bielle, F., Pollo, B., Paterra, R., et al. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-22-0376 · Cited by 24

Immune response in lung cancer mouse model mimics human anti-Hu reactivity

Kazarian, M., Calbó, J., Proost, N., Carpenter, C. L., Berns, A. J. M., & Laird‐Offringa, I. A. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.08.014 · Cited by 22

Review Paper: The Role of Inflammation in Mouse Pulmonary Neoplasia

Bauer, A. K., & Rondini, E. A. (2009) · Veterinary Pathology · doi:10.1354/vp.08-vp-0217-b-rev · Cited by 22

Animal Models of Lung Cancer

Wang, Y., Rouggly, L. C., You, M., & Lubet, R. A. (2011) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-394596-9.00007-x · Cited by 22

Role of PTEN in basal cell derived lung carcinogenesis

Malkoski, S. P., Cleaver, T. G., Thompson, J. J., Sutton, W., Haeger, S. M., Rodriguez, K. J., Lu, S., Merrick, D., & Wang, X. (2013) · Molecular Carcinogenesis · doi:10.1002/mc.22030 · Cited by 22

Is the Loss of pRb Essential for the Mouse Skin

Ruiz, S., Santos, M., & Paramio, J. M. (2006) · Cell Cycle · doi:10.4161/cc.5.6.2580 · Cited by 22

Identification of TAZ as the essential molecular switch in orchestrating SCLC phenotypic transition and metastasis

Jin, Y., Zhao, Q., Zhu, W., Feng, Y., Xiao, T., Zhang, P., Jiang, L., Hou, Y., Guo, C., Huang, H., et al. (2021) · National Science Review · doi:10.1093/nsr/nwab232 · Cited by 21

An integrative transcriptome analysis reveals a functional role for thyroid transcription factor‐1 in small cell lung cancer

Horie, M., Miyashita, N., Mattsson, J. S. M., Mikami, Y., Sandelin, M., Brunnström, H., Micke, P., Nagase, T., & Saito, A. (2018) · The Journal of Pathology · doi:10.1002/path.5109 · Cited by 21

Cancer

Hahn, W. C. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.007 · Cited by 21

NOTCH alteration in EGFR-mutated lung adenocarcinoma leads to histological small-cell carcinoma transformation under EGFR-TKI treatment

Koba, H., Kimura, H., Yoneda, T., Ogawa, N., Tanimura, K., Tambo, Y., Sone, T., Hosomichi, K., Tajima, A., & Kasahara, K. (2021) · Translational Lung Cancer Research · doi:10.21037/tlcr-21-536 · Cited by 20

Advancing immunotherapy in small cell lung cancer

Carlisle, J. W., & Leal, T. A. B. (2023) · Cancer · doi:10.1002/cncr.34977 · Cited by 20

The role of the NORE1A tumor suppressor in Oncogene-Induced Senescence

Barnoud, T., Schmidt, M., Donninger, H., & Clark, G. J. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.04.030 · Cited by 20

miR-215 promotes cell migration and invasion of gastric cancer by targeting Retinoblastoma tumor suppressor gene 1

Chen, Z., Liu, K., Li, L., Chen, Y., & Du, S. (2017) · Pathology - Research and Practice · doi:10.1016/j.prp.2017.06.006 · Cited by 20

Significantly mutated genes and regulatory pathways in SCLC—a meta-analysis

Sundaresan, V., Lin, V. T. G., Liang, F., Kaye, F. J., Kawabata‐Iwakawa, R., Shiraishi, K., Kohno, T., Yokota, J., & Zhou, L. J. (2017) · Cancer Genetics · doi:10.1016/j.cancergen.2017.05.003 · Cited by 20

Small cell lung cancer: emerging subtypes, signaling pathways, and therapeutic vulnerabilities

Zhang, J., Zeng, X., Guo, Q., Sheng, Z., Chen, Y., Wan, S., Zhang, L., & Zhang, P. (2024) · Experimental Hematology and Oncology · doi:10.1186/s40164-024-00548-w · Cited by 21

Epstein–Barr Virus Infection in Lung Cancer: Insights and Perspectives

Osorio, J. C., Blanco, R., Corvalán, A. H., Muñoz, J. P., Calaf, G. M., & Aguayo, F. (2022) · Pathogens · doi:10.3390/pathogens11020132 · Cited by 20

Targeting PEA3 transcription factors to mitigate small cell lung cancer progression

Shia, D. W., Choi, W., Vijayaraj, P., Vuong, V., Sandlin, J. M., Lu, M. M., Aziz, A. W., Marin, C., Aros, C. J., Sen, C., et al. (2022) · Oncogene · doi:10.1038/s41388-022-02558-6 · Cited by 18

Genomic profiling of small-cell lung cancer: the era of targeted therapies

Umemura, S., Tsuchihara, K., & Goto, K. (2015) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyv017 · Cited by 19

Distinct transcriptional programs of SOX2 in different types of small cell lung cancers

Tenjin, Y., Matsuura, K., Kudoh, S., Usuki, S., Yamada, T., Matsuo, A., Sato, Y., Saito, H., Fujino, K., Wakimoto, J., et al. (2020) · Laboratory Investigation · doi:10.1038/s41374-020-00479-0 · Cited by 19

Stem cells and lung cancer: future therapeutic targets?

Alison, M. R., Brenne, A. C. L., & Islam, S. (2009) · Expert Opinion on Biological Therapy · doi:10.1517/14712590903103803 · Cited by 19

NEMO- and RelA-dependent NF-κB signaling promotes small cell lung cancer

Koerner, L., Schmiel, M., Yang, T.-P., Peifer, M., Buettner, R., & Pasparakis, M. (2023) · Cell Death and Differentiation · doi:10.1038/s41418-023-01112-5 · Cited by 18

Experimental models for cancer brain metastasis

Liu, Z., Dong, S., Liu, M., Liu, Y., Ye, Z., Zeng, J., & Yao, M. (2023) · Cancer Pathogenesis and Therapy · doi:10.1016/j.cpt.2023.10.005 · Cited by 19

Inhibition of pituitary tumors in Rb mutant chimeras through E2f4 loss reveals a key suppressive role for the pRB/E2F pathway in urothelium and ganglionic carcinogenesis

Parisi, T., Bronson, R. T., & Lees, J. A. (2008) · Oncogene · doi:10.1038/onc.2008.406 · Cited by 19

Development of zebrafish medulloblastoma-like PNET model by TALEN-mediated somatic gene inactivation

Shim, J., Choi, J., Park, M.-H., Kim, H., Kim, J.-H., Kim, S., Hong, D., Kim, S., Lee, J. E., Kim, C., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.19424 · Cited by 18

Differential requirement for dimerization partner DP between E2F-dependent activation of tumor suppressor and growth-related genes

Komori, H., Goto, Y., Kurayoshi, K., Ozono, E., Iwanaga, R., Bradford, A. P., Araki, K., & Ohtani, K. (2018) · Scientific Reports · doi:10.1038/s41598-018-26860-0 · Cited by 18

Molecular and Genetic Pathogenesis of Lung Cancer: Differences Between Small-Cell and Non-Small-Cell Carcinomas

Kitamura, H., Yazawa, T., Okudela, K., Shimoyamada, H., & Sato, H. (2008) · The Open Pathology Journal · doi:10.2174/1874375700802010106 · Cited by 18

In Search of the Long-Desired ‘Copernican Therapeutic Revolution’ in Small-Cell Lung Cancer

Reguart, N., Marín, E., Remón, J., Reyes, R., & Teixidó, C. (2020) · Drugs · doi:10.1007/s40265-019-01240-8 · Cited by 18

New approaches for modelling sporadic genetic disease in the mouse

Fisher, E., Lana‐Elola, E., Watson, S. D., Vassiliou, G. S., & Tybulewicz, V. L. J. (2009) · Disease Models & Mechanisms · doi:10.1242/dmm.001644 · Cited by 19

Practical Use of Advanced Mouse Models for Lung Cancer

Safari, R., & Meuwissen, R. L. J. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2297-0_5 · Cited by 17

Genomic predictors of radiation response: recent progress towards personalized radiotherapy for brain metastases

Harary, P. M., Rajaram, S., Chen, M. S., Hori, Y. S., Park, D. J., & Chang, S. D. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-02270-2 · Cited by 20

Simultaneous Activation of Kras and Inactivation of p53 Induces Soft Tissue Sarcoma and Bladder Urothelial Hyperplasia

Yang, X., Rosa, F. G. L., Genova, E. E., Huber, K. M., Schaack, J. B., DeGregori, J. V., Serkova, N. J., Li, Y., Su, L., Kessler, E. R., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074809 · Cited by 17

Selective gene expression analysis of the neuroepithelial body microenvironment in postnatal lungs with special interest for potential stem cell characteristics

Verckist, L., Lembrechts, R., Thys, S., Pintelon, I., Timmermans, J., Brouns, I., & Adriaensen, D. (2017) · Respiratory Research · doi:10.1186/s12931-017-0571-4 · Cited by 17

Mouse models of endocrine tumors

Gahete, M. D., Jiménez‐Vacas, J. M., Alors‐Pérez, E., Herrero‐Aguayo, V., Fuentes-Fayos, A. C., Pedraza‐Arévalo, S., Castano, J. P., & Luque, R. M. (2018) · Journal of Endocrinology · doi:10.1530/joe-18-0571 · Cited by 17

Are there any theranostic biomarkers in small cell lung carcinoma?

Pezzuto, F., Fortarezza, F., Lunardi, F., & Calabrese, F. (2019) · Journal of Thoracic Disease · doi:10.21037/jtd.2018.12.14 · Cited by 17

Inhibition of Karyopherin β1-Mediated Nuclear Import Disrupts Oncogenic Lineage-Defining Transcription Factor Activity in Small Cell Lung Cancer

Kelenis, D. P., Rodarte, K. E., Kollipara, R. K., Pozo, K., Choudhuri, S. P., Spainhower, K. B., Wait, S. J., Stastny, V., Oliver, T. G., & Johnson, J. E. B. (2022) · Cancer Research · doi:10.1158/0008-5472.can-21-3713 · Cited by 17

Small-cell lung cancer with a rare epidermal growth factor receptor gene mutation showing “wax-and-wane” transformation

Takagi, Y., Nakahara, Y., Hosomi, Y., & Hishima, T. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-529 · Cited by 18

Trp53 and Rb1 regulate autophagy and ligand-dependent Hedgehog signaling

Cochrane, C. R., Vaghjiani, V., Szczepny, A., Jayasekara, W. S. N., González-Rajal, Á., Kikuchi, K., McCaughan, G. W., Burgess, A., Gough, D. J., Watkins, D. N., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci132513 · Cited by 19

The role of cancer stem cells in neoplasia of the lung: past, present and future

Yagui‐Beltrán, A., He, B., & Jablons, D. M. (2008) · Clinical & Translational Oncology · doi:10.1007/s12094-008-0278-6 · Cited by 17

Dopamine D2 receptor agonists abrogate neuroendocrine tumour angiogenesis to inhibit chemotherapy-refractory small cell lung cancer progression

Alam, S. K., Pandit, A., Wang, L., Farsani, S. S. M., Thiele, B., Manoj, P., Aubry, M. C., Verma, V., Rudin, C. M., Lo, Y., et al. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07693-y · Cited by 16

Heterogeneity of Pulmonary Stem Cells

Lynch, T. J., Ievlev, V., & Parekh, K. R. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-24108-7_6 · Cited by 16

TP53, CDKN2A/P16, and NFE2L2/NRF2 regulate the incidence of pure- and combined-small cell lung cancer in mice

Hamad, S. H., Montgomery, S. A., Simon, J. M., Bowman, B. M., Spainhower, K. B., Murphy, R. M., Knudsen, E. S., Fenton, S. E., Randell, S. H., Holt, J. R., et al. (2022) · Oncogene · doi:10.1038/s41388-022-02348-0 · Cited by 15

WNT5A–RHOA Signaling Is a Driver of Tumorigenesis and Represents a Therapeutically Actionable Vulnerability in Small Cell Lung Cancer

Kim, K., Kim, D.-W., Kim, Y., Tang, J., Kirk, N., Gan, Y., Kim, B.-J., Fang, B., Park, J., Zheng, Y., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-22-1170 · Cited by 16

Effect of chromatin modifiers on the plasticity and immunogenicity of small-cell lung cancer

Kirk, N. A., Kim, K., & Park, K.-S. (2022) · Experimental & Molecular Medicine · doi:10.1038/s12276-022-00905-x · Cited by 17

Retinoblastoma Function Is Essential for Establishing Lung Epithelial Quiescence after Injury

Mason-Richie, N. A., Mistry, M. J., Gettler, C. A., Elayyadi, A., & Wikenheiser‐Brokamp, K. A. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5667 · Cited by 17

Autochthonous murine models for the study of smoker and never-smoker associated lung cancers

Akbay, E. A., & Kim, J. (2018) · Translational Lung Cancer Research · doi:10.21037/tlcr.2018.06.04 · Cited by 16

Small Cell Lung Cancer Derived from Adenocarcinoma with Mutant Epidermal Growth Factor Receptor Provides a Signature of Transcriptional Alteration in Tumor Cells

Tenjin, Y., Nakamura, K., Ishizuka, S., Saruwatari, K., Sato, R., Tomita, Y., Saeki, S., Ichiyasu, H., Fujii, K., Ito, T., et al. (2019) · Internal Medicine · doi:10.2169/internalmedicine.2988-19 · Cited by 16

Anchorage-Independent Growth of Pocket Protein-Deficient Murine Fibroblasts Requires Bypass of G2 Arrest and Can Be Accomplished by Expression of TBX2

Vormer, T. L., Foijer, F., Wielders, C. L. C., & Riele, H. T. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00313-08 · Cited by 16

Optimized Bexarotene Aerosol Formulation Inhibits Major Subtypes of Lung Cancer in Mice

Zhang, Q., Lee, S. B., Chen, X., Stevenson, M. E., Pan, J., Xiong, D., Zhou, Y., Miller, M. S., Lubet, R. A., Wang, Y., et al. (2019) · Nano Letters · doi:10.1021/acs.nanolett.8b04309 · Cited by 16

Effects of Granulosa Cell-Specific Deletion of Rb in Inha-α Null Female Mice

Andreu‐Vieyra, C., Chen, R., & Matzuk, M. M. (2007) · Endocrinology · doi:10.1210/en.2006-1590 · Cited by 16

REST Inactivation and Coexpression of ASCL1 and POU3F4 Are Necessary for the Complete Transformation of RB1/TP53-Inactivated Lung Adenocarcinoma into Neuroendocrine Carcinoma

Masawa, M., Sato‐Yazawa, H., Kashiwagi, K., Ishii, J., Miyata-Hiramatsu, C., Iwamoto, M., Kohno, K., Miyazawa, T., Onozaki, M., Noda, S., et al. (2022) · American Journal Of Pathology · doi:10.1016/j.ajpath.2022.03.007 · Cited by 15

Combinatorial Inactivation of Tumor Suppressors Efficiently Initiates Lung Adenocarcinoma with Therapeutic Vulnerabilities

Yousefi, M., Boross, G. Z., Weiss, C. V., Murray, C. W., Hebert, J. D., Cai, H., Ashkin, E. L., Karmakar, S., Andrejka, L., Chen, L. C., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-22-0059 · Cited by 15

Understanding SCLC heterogeneity and plasticity in cancer metastasis and chemotherapy resistance

Jin, Y., Chen, Y., Qin, Z., Hu, L., Guo, C., & Ji, H. (2023) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2023080 · Cited by 16

p16 controls epithelial cell growth and suppresses carcinogenesis through mechanisms that do not require RB1 function

Sen, M., Akeno, N., Reece, A. L., Miller, A. L., Simpson, D. S., & Wikenheiser‐Brokamp, K. A. (2017) · Oncogenesis · doi:10.1038/oncsis.2017.5 · Cited by 15

TRP53 Mutants Drive Neuroendocrine Lung Cancer Through Loss-of-Function Mechanisms with Gain-of-Function Effects on Chemotherapy Response

Akeno, N., Reece, A. L., Callahan, M. K., Miller, A. L., Kim, R. G., He, D., Lane, A., Moulton, J. S., & Wikenheiser‐Brokamp, K. A. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0353 · Cited by 15

Mouse Lung Neuroendocrine Carcinomas: Distinct Morphologies, Same Transcription Factors

Linnoila, R. I., Naizhen, X., Meuwissen, R. L. J., Berns, A. J. M., & DeMayo, F. J. (2004) · Experimental Lung Research · doi:10.1080/01902140490495002 · Cited by 15

Pulmonary Neuroendocrine Cell Hyperplasia: Identification, Diagnostic Criteria and Incidence in Untreated Ageing Rats of Different Strains

Haworth, R., Woodfine, J. A., McCawley, S. J., Pilling, A. M., Lewis, D. J., & Williams, T. C. (2007) · Toxicologic Pathology · doi:10.1080/01926230701460000 · Cited by 15

Integrated Analysis of Transcriptomes of Cancer Cell Lines and Patient Samples Reveals STK11/LKB1–Driven Regulation of cAMP Phosphodiesterase-4D

He, N., Kim, N., Song, M., Park, C., Kim, S., Park, E. Y., Yim, H. Y., Kim, K., Park, J. H., Kim, K. I., et al. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0297 · Cited by 15

Protein neddylation as a therapeutic target in pulmonary and extrapulmonary small cell carcinomasPreprint

Norton, J. P., Augert, A., Eastwood, E., Basom, R., Rudin, C. M., & MacPherson, D. P. (2021) · Genes & Development · doi:10.1101/gad.348316.121 · Cited by 16

Noninvasive molecular imaging using anti-Trop-2 aptamer for targeted therapy of small cell lung cancer

Chen, Y., Liu, X., Sun, Y., Liu, K., Ding, D., Song, S., & Tan, W. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03184-6 · Cited by 14

RNF20 links the DNA damage response and metabolic rewiring in lung cancer through HIF1α

Liu, H., Tang, Y., Singh, A., Vong, J. S. L., Cordero, J., Mathes, A., Gao, R., Jia, Y., Garvalov, B. K., Acker, T., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-60223-4 · Cited by 14

Small cell lung cancer; recent advances of its biology and therapeutic perspective

Hayashi, R., & Inomata, M. (2021) · Respiratory Investigation · doi:10.1016/j.resinv.2021.10.008 · Cited by 14

CDK9 inhibition as an effective therapy for small cell lung cancer

Capuccino, L. V., Kleitke, T., Szokol, B., Svajda, L., Martín, F., Bonechi, F., Krekó, M., Azami, S., Montinaro, A., Wang, Y., et al. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06724-4 · Cited by 14

Cell plasticity in patients with NSCLC: The controversial origins of transformed SCLC

Liang, X., Lin, A., Wang, Q., Zhang, J., & Luo, P. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112909 · Cited by 14

Pre-clinical imaging for establishment and comparison of orthotopic non-small cell lung carcinoma: in search for models reflecting clinical scenarios

Aktar, R., Dietrich, A., Tillner, F., Kotb, S., Löck, S., Willers, H., Baumann, M. A., Krause, M., & Bütof, R. (2018) · British Journal of Radiology · doi:10.1259/bjr.20180539 · Cited by 14

THE MOUSE TUMOR BIOLOGY DATABASE: INTEGRATED ACCESS TO MOUSE CANCER BIOLOGY DATA

Krupke, D. M., Näf, D., Vincent, M. J., Allio, T., Mikaelian, I., Sundberg, J. P., Bult, C. J., & Eppig, J. T. (2005) · Experimental Lung Research · doi:10.1080/01902140490495633 · Cited by 14

The evolving landscape of brain metastasis: volume II

Valiente, M., Anders, C. K., Boire, A. A., Izar, B., Kotecki, N., Malladi, S., Massagué, J., Moss, N. S., Neman, J., Preusser, M., et al. (2025) · Trends in cancer · doi:10.1016/j.trecan.2025.11.007 · Cited by 16

ERBB2 signaling drives immune cell evasion and resistance against immunotherapy in small cell lung cancer

Meder, L., Orschel, C. I., Bouchez, C. L., Gholamipoorfard, R., Orschel, C. V., Stahl, D. J., Kreer, C., Koker, M., Nill, M., Kocak, I. G., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-66800-x · Cited by 13

Progress in the knowledge on the transformation of lung adenocarcinoma to small-cell lung cancer

Wang, A., Han, C., Zhao, H., Zheng, Z., Ye, X., & Shan, R. (2023) · Journal of Cancer Research and Therapeutics · doi:10.4103/jcrt.jcrt_1842_22 · Cited by 14

Small Cell Lung Cancer Plasticity Enables NFIB-Independent Metastasis

Ko, J. H., Lambert, K. E., Bhattacharya, D., Lee, M. C., Colón, C. I., Hauser, H. F., & Sage, J. (2023) · Cancer Research · doi:10.1158/0008-5472.can-23-1079 · Cited by 13

COX6C expression driven by copy amplification of 8q22.2 regulates cell proliferation via mediation of mitosis by ROS-AMPK signaling in lung adenocarcinoma

Liu, S., Shao, F., Wang, Y., Zhang, Y., Yu, H., Zhang, N., He, L., Kong, Q., Jiang, H., & Dong, Z. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06443-w · Cited by 13

Blocking the angiopoietin-2–dependent integrin β-1 signaling axis abrogates small cell lung cancer invasion and metastasis

Meder, L., Orschel, C. I., Otto, C. J., Koker, M., Brägelmann, J., Ercanoglu, M. S., Dähling, S., Compes, A., Selenz, C., Nill, M., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.166402 · Cited by 13

Lung Cancers and the Roles of Natural Compounds as Potential Chemotherapeutic and Chemopreventive Agents

Surien, O., Ghazali, A. R., & Masre, S. F. (2019) · Biomedical & Pharmacology Journal · doi:10.13005/bpj/1617 · Cited by 13

Recent advances in histogenesis research of lung neuroendocrine cancers: Evidence obtained from functional analyses of primitive neural/neuroendocrine cell‐specific transcription factors

Yazawa, T. (2015) · Pathology International · doi:10.1111/pin.12267 · Cited by 13

Atypical pulmonary carcinoid tumour in a 28-year-old nonsmoker with Prader–Willi syndrome: Figure 1–

Nenekidis, I., Stathopoulos, G. T., Anagnostakou, V., Kokkori, A., Dedeilias, P., Kokotsakis, J. N., Argiriou, M., & Zisis, C. (2011) · European Respiratory Journal · doi:10.1183/09031936.00034711 · Cited by 13

Ablating all three retinoblastoma family members in mouse lung leads to neuroendocrine tumor formation

Lázaro, S., Pérez-Crespo, M., Enguita, A. B., Hernández, P., Martínez‐Palacio, J., Oteo, M., Sage, J., Paramio, J. M., & Santos, M. (2016) · Oncotarget · doi:10.18632/oncotarget.13875 · Cited by 13

Different strokes

Greenwood, E. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1216 · Cited by 2

Abstract SY10-02: Mouse models for (non) small cell lung cancer: Heterogeneity and cell of origin

Berns, A. J. M., Sutherland, K., Kwon, M. C., Proost, N., & Calbó, J. (2012) · Cancer Research · doi:10.1158/1538-7445.am2012-sy10-02

Cell of Origin of Small Cell Lung Cancer: Inactivation of Trp53 and Rb1 in Distinct Cell Types of Adult Mouse Lung

Sutherland, K. D., Proost, N., Brouns, I., Adriaensen, D., Song, J.-Y., & Berns, A. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.04.019 · Cited by 534

MS32.01 Genetic Mouse Models (GEMMS)

Mollaoglu, G., Chalishazar, M. D., Huang, F., Guthrie, M. R., Böhm, S., Br€Agelmann, J., Sen, T., Byers, L. A., Johnson, J. L., Wechsler‐Reya, R. J., et al. (2018) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2018.08.208

Loss of p130 Accelerates Tumor Development in a Mouse Model for Human Small-Cell Lung Carcinoma

Schaffer, B. E., Park, K.-S., Yiu, G., Conklin, J. F., Lin, C., Burkhart, D. L., Karnezis, A. N., Sweet-Cordero, A., & Sage, J. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4228 · Cited by 248